InsidersTradesSigma
Follow the Instil Bio, Inc. stock price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Operating in the Health Care sector, Instil Bio, Inc. has recorded 2 insider filings. Market capitalisation: €50.3m. The latest transaction was reported on 12 September 2025 (Levée d'options). Among the most active insiders: Laumas Sandeep. Every trade is free.
2
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Instil Bio, Inc. Hold (neutral), based on 1 analysts. Average price target: US$7.00.
27Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 September 2025
Declarations2 total
17,000 shares@ US$11.60100.0% of flowCommon StockSEC:0001789769-25-000087:0
260,323 shares0Common StockSEC:0001567619-22-007150:0
2 of 2 declarations
关于 Instil Bio, Inc.
Instil Bio, Inc. 是一家生物制药公司，专注于开发用于癌症治疗的细胞疗法。该公司利用先进技术创造创新和个性化的疗法。